Table 1 Demographics and clinical characteristics of COVID-19 patients on admission
Total(n = 252) | Non-critically ill (n = 200) | Critically ill (n = 52) | P value | |
|---|---|---|---|---|
Age, years | 49(37–61) | 45 (35.25–56) | 64 (52–73) | < 0.0001 |
< 30 | 26 (10.30) | 25 (12.50) | 1 (1.90) | < 0.0001 |
30–39 | 48 (19.00) | 44 (22.00) | 4 (7.70) | |
40–49 | 58 (23.00) | 54 (27.00) | 4 (7.70) | |
50–59 | 50 (19.80) | 39 (19.50) | 11 (21.20) | |
60–69 | 44 (17.50) | 28 (14.00) | 16 (30.80) | |
70–79 | 16 (6.30) | 5 (2.50) | 11 (21.20) | |
≥ 80 | 10 (4.00) | 5 (2.50) | 5 (9.60) | |
Sex | ||||
Female | 111 (44.00) | 90 (45.00) | 21 (40.40) | 0.55 |
Male | 141 (56.00) | 110 (55.00) | 31 (59.60) | |
Signs and symptoms | ||||
Fever(≥ 37.3 °C) | 179 (71.00) | 150 (75.00) | 29 (55.80) | 0.006 |
Cough | 177 (70.20) | 136 (68.00) | 41 (78.80) | 0.128 |
Myalgia | 42 (16.70) | 35 (17.50) | 7 (13.50) | 0.486 |
Cephalalgia | 22 (8.70) | 18 (9.00) | 4 (7.70) | 0.983 |
Sputum | 105 (41.70) | 88 (44.00) | 17 (32.70) | 0.141 |
Hemoptysis | 4 (1.80) | 2 (1.20) | 2 (3.80) | 0.243 |
Diarrhoea | 28 (11.10) | 21 (10.50) | 7 (13.50) | 0.545 |
Dyspnea | 35 (13.90) | 6 (3.00) | 29 (55.80) | < 0.0001 |
Respiratory rate > 24 breaths per min | 26 (10.40) | 7 (3.60) | 19 (36.50) | < 0.0001 |
Comorbidity | ||||
Hypertension | 48 (19.00) | 28 (14.00) | 20 (38.50) | < 0.0001 |
Diabetes | 18 (7.20) | 10 (5.00) | 8 (15.70) | 0.019 |
Digestive tract disease | 4 (1.60) | 3 (1.50) | 1 (1.90) | 1 |
Cardiovascular disease | 10 (40) | 4 (2.00) | 6 (11.50) | 0.006 |
Cerebrovascular disease | 3 (1.20) | 1 (0.50) | 2 (3.80) | 0.109 |
Malignancy | 4 (1.60) | 1 (0.50) | 3 (5.80) | 0.029 |
Liver disease | 6 (2.40) | 3 (1.50) | 3 (5.80) | 0.198 |